Lv1
20 积分 2022-11-29 加入
Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors
6天前
已完结
Abstract LB313: Advancing iPSC derived CAR NK cell therapy for enhanced solid tumor treatment
19天前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
20天前
已完结
TIM3 Blockade in Dendritic Cells May Potentiate Antitumor Immunity
1个月前
已完结
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models
2个月前
已完结
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models
2个月前
已完结
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells
3个月前
已完结
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells
3个月前
已完结
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy
3个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
5个月前
已完结
皖公网安备34019202002308
